Yahoo

Correo

U.S. markets open in 29 minutes

F S&P 500
5,367.25
+39.25(+0.74%)
F Dow Jones
39,866.00
+83.00(+0.21%)
F Nasdaq
19,017.00
+230.25(+1.23%)
E-mini Russell 2000 Index Futur
2,098.70
+9.60(+0.46%)
Petróleo
78.27
+0.70(+0.90%)
Oro
2,364.80
-28.10(-1.17%)

iTeos Therapeutics, Inc. (ITOS)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.

Añadir a la lista de seguimiento

17.86

-0.17

(-0.94%)

Al cierre: 04:00PM EDT

18.10

+0.24

(+1.34%)

Fuera de horario:

06:40PM EDT

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Divisa en USD

Compras de miembros de la gerencia en los últimos 6 meses	Acciones	Trans
Compras	0	0
Ventas	N/D	0
Acciones netas compradas (vendidas)	0	0
Acciones totales pertenecientes a miembros de la gerencia	254.67k	N/D
Acciones netas compradas (vendidas) en %	N/D	N/D

Compras institucionales netas del trimestre anterior al último	Acciones
Acciones netas compradas (vendidas)	N/D
Cambio en acciones institucionales propias en %	N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerencia	Transacción	Tipo	Valor	Fecha	Acciones
BOXER CAPITAL L L C Unknown	Stock Award(Grant) at price 17.50 per share.	Indirecto	19,999,998	10 may 2024	1,142,857
DETHEUX MICHEL Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	05 dic 2023	30,000
GALL MATTHEW Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	05 dic 2023	41,000
MCGRATH YVONNE Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	05 dic 2023	31,000
CALL MATTHEW A MBA Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	05 dic 2023	44,000
GALL MATTHEW Chief Financial Officer	Purchase at price 8.37 per share.	Directo	41,850	12 oct 2023	5,000
BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security	Sale at price 13.50 - 15.63 per share.	Indirecto	4,952,493	23 ago 2023	350,000
CALL MATTHEW A MBA Chief Operating Officer	Conversion of Exercise of derivative security at price 2.95 per share.	Directo	118,667	28 mar 2023	40,226
HALLAL DAVID L Director	Sale at price 19.51 - 20.39 per share.	Directo	597,214	09 jun 2022	29,615
HALLAL DAVID L Director	Conversion of Exercise of derivative security at price 2.95 - 4.23 per share.	Directo	110,041	09 jun 2022	29,615
DAVIS AARON I Director	Sale at price 22.91 - 25.63 per share.	Indirecto	16,444,752	11 may 2022	663,000
DAVIS AARON I Director	Sale at price 26.91 - 28.22 per share.	Indirecto	10,247,871	02 may 2022	375,000
DETHEUX MICHEL Chief Executive Officer	Sale at price 31.87 - 32.64 per share.	Directo	366,530	18 abr 2022	11,500
DETHEUX MICHEL Chief Executive Officer	Conversion of Exercise of derivative security at price 4.23 per share.	Directo	48,645	18 abr 2022	11,500
DAVIS AARON I Director	Purchase at price 31.88 - 33.43 per share.	Indirecto	1,625,489	23 mar 2022	50,000
DETHEUX MICHEL Chief Executive Officer	Sale at price 33.44 - 36.51 per share.	Directo	629,987	22 mar 2022	18,437
BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.25 per share.	Indirecto	20,275,835	17 mar 2022	575,201
DETHEUX MICHEL Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	11 mar 2022	10,000
LAGER JOANNE JENKINS M.D. Officer	Sale at price 36.01 per share.	Directo	126,035	11 mar 2022	3,500
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	15,050	11 mar 2022	3,500
MCGRATH YVONNE Officer	Sale at price 36.76 per share.	Directo	367,570	01 mar 2022	10,000
MCGRATH YVONNE Officer	Conversion of Exercise of derivative security at price 4.24 per share.	Directo	42,400	01 mar 2022	10,000
DETHEUX MICHEL Chief Executive Officer	Sale at price 34.30 - 35.32 per share.	Directo	497,905	23 feb 2022	14,500
LAGER JOANNE JENKINS M.D. Officer	Sale at price 35.52 - 36.27 per share.	Directo	125,458	11 feb 2022	3,500
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	15,050	11 feb 2022	3,500
DETHEUX MICHEL Chief Executive Officer	Sale at price 35.45 - 36.21 per share.	Directo	517,378	25 ene 2022	14,500
LAGER JOANNE JENKINS M.D. Officer	Sale at price 39.25 - 39.58 per share.	Directo	137,614	14 ene 2022	3,500
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	15,050	14 ene 2022	3,500
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 42.03 - 46.47 per share.	Indirecto	10,452,334	05 ene 2022	245,469
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 42.03 - 46.47 per share.	Indirecto	6,246,050	05 ene 2022	146,685
BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security	Sale at price 41.84 - 50.63 per share.	Indirecto	32,575,642	04 ene 2022	700,000
BINISZKIEWICZ DETLEV Director	Sale at price 51.90 per share.	Directo	181,650	03 ene 2022	3,500
BINISZKIEWICZ DETLEV Director	Conversion of Exercise of derivative security at price 19.00 per share.	Directo	66,500	03 ene 2022	3,500
LAGER JOANNE JENKINS M.D. Officer	Sale at price 51.90 per share.	Directo	363,300	03 ene 2022	7,000
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	30,100	03 ene 2022	7,000
GALL MATTHEW Chief Financial Officer	Sale at price 46.45 per share.	Directo	232,250	27 dic 2021	5,000
DETHEUX MICHEL Chief Executive Officer	Sale at price 43.94 - 45.37 per share.	Directo	1,982,131	22 dic 2021	44,500
DETHEUX MICHEL Chief Executive Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	129,000	22 dic 2021	30,000
HALLAL DAVID L Director	Sale at price 43.57 per share.	Directo	2,178,500	20 dic 2021	50,000
HALLAL DAVID L Director	Conversion of Exercise of derivative security at price 2.95 - 4.30 per share.	Directo	174,500	20 dic 2021	50,000
LAGER JOANNE JENKINS M.D. Officer	Sale at price 41.00 per share.	Directo	287,000	17 dic 2021	7,000
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	30,100	17 dic 2021	7,000
LAGER JOANNE JENKINS M.D. Officer	Sale at price 34.50 per share.	Directo	120,750	10 dic 2021	3,500
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	15,050	10 dic 2021	3,500
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 32.35 - 36.26 per share.	Indirecto	2,812,428	07 dic 2021	83,390
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 32.35 - 36.26 per share.	Indirecto	1,680,611	07 dic 2021	49,831
MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 32.35 - 36.26 per share.	Indirecto	1,680,611	07 dic 2021	49,831
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 33.74 - 35.34 per share.	Indirecto	4,817,417	02 dic 2021	139,773
MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 33.74 - 35.34 per share.	Indirecto	2,878,562	02 dic 2021	83,519
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 34.46 - 36.03 per share.	Indirecto	1,356,825	29 nov 2021	38,566
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 34.46 - 36.03 per share.	Indirecto	810,766	29 nov 2021	23,045
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.20 - 37.81 per share.	Indirecto	4,744,666	24 nov 2021	129,617
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.20 - 37.81 per share.	Indirecto	2,835,263	24 nov 2021	77,455
DETHEUX MICHEL Chief Executive Officer	Sale at price 36.08 per share.	Directo	523,160	23 nov 2021	14,500
DETHEUX MICHEL Chief Executive Officer	Conversion of Exercise of derivative security at price 12.45 per share.	Directo	202,474	22 nov 2021	16,263
LAGER JOANNE JENKINS M.D. Officer	Sale at price 34.50 per share.	Directo	966,000	18 nov 2021	28,000
LAGER JOANNE JENKINS M.D. Officer	Conversion of Exercise of derivative security at price 4.30 per share.	Directo	120,400	18 nov 2021	28,000
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.00 - 28.89 per share.	Directo	586,966	03 nov 2021	20,557
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.00 per share.	Directo	5,488	21 oct 2021	196
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.00 - 28.01 per share.	Directo	51,424	19 oct 2021	1,836
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.14 - 28.01 per share.	Indirecto	785,384	18 oct 2021	28,615
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.14 - 28.01 per share.	Indirecto	469,309	18 oct 2021	17,099
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.09 - 27.30 per share.	Indirecto	2,584,606	14 oct 2021	95,002
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.09 - 27.30 per share.	Indirecto	1,544,474	14 oct 2021	56,770
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.00 - 27.24 per share.	Indirecto	2,368,800	11 oct 2021	87,006
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.00 - 27.24 per share.	Indirecto	1,415,546	11 oct 2021	51,993
GALL MATTHEW Chief Financial Officer	Conversion of Exercise of derivative security at price 6.16 per share.	Directo	88,883	11 oct 2021	14,429
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.00 - 27.06 per share.	Indirecto	1,247,590	04 oct 2021	46,130
MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.00 - 27.06 per share.	Indirecto	745,525	04 oct 2021	27,566
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.00 per share.	Indirecto	971,730	30 sept 2021	35,990
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.00 per share.	Indirecto	580,662	30 sept 2021	21,506
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.09 - 28.38 per share.	Indirecto	2,484,094	27 sept 2021	89,476
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.09 - 28.38 per share.	Indirecto	1,484,416	27 sept 2021	53,468
MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.09 - 28.38 per share.	Indirecto	1,484,416	27 sept 2021	53,468
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.02 - 28.16 per share.	Directo	180,374	24 sept 2021	6,411
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.47 - 27.54 per share.	Indirecto	1,561,394	22 sept 2021	56,779
MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.47 - 27.54 per share.	Indirecto	933,030	22 sept 2021	33,929
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.03 - 28.82 per share.	Indirecto	4,334,452	20 sept 2021	152,711
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.03 - 28.82 per share.	Indirecto	2,590,097	20 sept 2021	91,254
MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.03 - 28.82 per share.	Indirecto	2,590,097	20 sept 2021	91,254
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.50 - 28.15 per share.	Indirecto	2,116,733	15 sept 2021	76,417
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.50 - 28.15 per share.	Indirecto	1,264,910	15 sept 2021	45,665
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.64 - 28.97 per share.	Indirecto	2,731,460	13 sept 2021	96,456
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 27.64 - 28.97 per share.	Indirecto	1,632,261	13 sept 2021	57,640
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 28.61 - 29.18 per share.	Indirecto	2,067,786	08 sept 2021	71,232
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 28.61 - 29.18 per share.	Indirecto	1,235,644	08 sept 2021	42,566
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.30 - 29.49 per share.	Directo	580,518	02 sept 2021	20,252
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.01 - 28.17 per share.	Directo	412,481	31 ago 2021	14,663
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.00 - 28.26 per share.	Directo	240,890	25 ago 2021	8,585
CALL MATTHEW A MBA Chief Operating Officer	Conversion of Exercise of derivative security at price 2.95 per share.	Directo	158,332	30 jul 2021	53,672
GALL MATTHEW Chief Financial Officer	Purchase at price 26.09 per share.	Directo	130,446	16 jun 2021	5,000
DETHEUX MICHEL Chief Executive Officer	Sale at price 28.38 - 29.26 per share.	Directo	826,534	14 jun 2021	29,000
MCGRATH YVONNE Officer	Sale at price 20.00 per share.	Directo	158,540	08 jun 2021	7,927
MCGRATH YVONNE Officer	Conversion of Exercise of derivative security at price 4.23 per share.	Directo	33,531	08 jun 2021	7,927
MCGRATH YVONNE Officer	Sale at price 20.00 - 20.18 per share.	Directo	159,903	02 jun 2021	7,927
MCGRATH YVONNE Officer	Conversion of Exercise of derivative security at price 4.23 per share.	Directo	33,531	02 jun 2021	7,927
MCGRATH YVONNE Officer	Sale at price 21.92 per share.	Directo	173,796	24 may 2021	7,927
MCGRATH YVONNE Officer	Conversion of Exercise of derivative security at price 4.23 per share.	Directo	33,531	24 may 2021	7,927
MCGRATH YVONNE Officer	Sale at price 21.92 per share.	Directo	173,796	24 may 2021	7,927
MCGRATH YVONNE Officer	Conversion of Exercise of derivative security at price 4.23 per share.	Directo	33,531	24 may 2021	7,927
MCGRATH YVONNE Officer	Sale at price 24.41 - 26.01 per share.	Directo	195,719	17 may 2021	7,926
MCGRATH YVONNE Officer	Conversion of Exercise of derivative security at price 4.23 per share.	Directo	33,527	17 may 2021	7,926
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 29.99 per share.	Indirecto	5,998	09 abr 2021	200
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 29.99 per share.	Indirecto	3,569	09 abr 2021	119
GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security	Sale at price 30.51 - 33.84 per share.	Indirecto	1,300,850	08 abr 2021	41,982
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 30.51 - 33.84 per share.	Indirecto	777,343	08 abr 2021	25,087
GADICKE ANSBERT S. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.00 per share.	Indirecto	6,080,000	28 jul 2020	320,000
GADICKE ANSBERT S. Director and Beneficial Owner of more than 10% of a Class of Security		Indirecto		28 jul 2020	5,742,220
BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.00 per share.	Indirecto	27,075,000	28 jul 2020	1,425,000
BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security		Indirecto		28 jul 2020	2,992,259
DAVIS AARON I Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.00 per share.	Indirecto	27,075,000	28 jul 2020	1,425,000
DAVIS AARON I Director and Beneficial Owner of more than 10% of a Class of Security		Indirecto		28 jul 2020	2,992,259
RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.00 per share.	Indirecto	27,075,000	28 jul 2020	1,425,000
RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security		Indirecto		28 jul 2020	2,992,259
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.00 per share.	Indirecto	3,040,000	28 jul 2020	160,000
MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security		Indirecto		28 jul 2020	3,546,663

F S&P 5005,367.25+39.25(+0.74%)

F Dow Jones39,866.00+83.00(+0.21%)

F Nasdaq19,017.00+230.25(+1.23%)

E-mini Russell 2000 Index Futur2,098.70+9.60(+0.46%)

Petróleo78.27+0.70(+0.90%)

Oro2,364.80-28.10(-1.17%)

iTeos Therapeutics, Inc. (ITOS)

Transacciones de miembros de la gerencia

Información confidencial de transacciones reportada (últimos dos años)

F S&P 500
5,367.25
+39.25(+0.74%)

F Dow Jones
39,866.00
+83.00(+0.21%)

F Nasdaq
19,017.00
+230.25(+1.23%)

E-mini Russell 2000 Index Futur
2,098.70
+9.60(+0.46%)

Petróleo
78.27
+0.70(+0.90%)

Oro
2,364.80
-28.10(-1.17%)